During the past decade, Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are "Lymphoma" (1 trials) and "Metastatic gpNMB Over-expressing Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" in a lesser frequency.

Most popular intervention types in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CDX-011" (1 trials), "Capecitabine" (1 trials), "cyclophosphamide" (1 trials), "doxorubicin hydrochloride" (1 trials) and "pegfilgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".